Previous issue | Volume 84 | ESPE2015 | Next issue

54th Annual ESPE

Barcelona, Spain
01 Oct 2015 - 03 Oct 2015

Card image cap
Barcelona, Spain; 1-3 October 2015 Further information

Free Communications

Growth

Heterozygous Dominant Negative STAT5B Variants associated with Short Stature and GH Insensitivity
aBarts Health NHS Trust/Queen Mary University London, London, UK; bUniversity Hospital Hradec Kralove, Hradec Kralove, Czech Republic; cUniversity of Leipzig, Leipzig, Germany; dCincinnati Children’s Hospital Medical Center, Cincinnati, Ohio, USA; eGreat Ormond Street Hospital, London, UK
hrp0084fc4.1
A Recurrent Homozygous NDUFB3 Mutation, p.Trp22Arg Causes a Short Stature Disorder and Mitochondrial Protein Complex I Deficiency with a Variable Metabolic Phenotype
aUniversity of Manchester, Manchester, UK; bRoyal Manchester Children’s Hospital, Manchester, UK; cNewcastle University, Newcastle, UK; dUniversity of Bristol, Bristol, UK; eBristol Royal Children’s Hospital, Bristol, UK; fTemple Street Children’s University Hospital, Dublin, Ireland
hrp0084fc4.2
An Updated and Final Analysis of a Randomised Placebo-controlled Trial of the Effect of Oxandrolone and Timing of Pubertal Induction on Final Height in Turner Syndrome
aUniversity of Glasgow, Glasgow, UK; bUniversity College London, London, UK; cRoyal Hospital for Sick Children, Glasgow, UK; dSouthamptom University Hospitals NHS Trust, Southampton, UK; eUniversity of Cambridge, Cambridge, UK
hrp0084fc4.3
Modulation of GH-1 Splicing as Potential Strategy to Rescue GH Deficiency Type II
Division of Paediatric Endocrinology, Diabetology and Metabolism and Department of Clinical Research, University Children’s Hospital, Bern, Switzerland
hrp0084fc4.4
Stunted Growth after Inhaled Corticosteroid Use during the First 24 Months of Life
aKuopio University Hospital, Kuopio, Finland; bSocial Insurance Institution, Turku, Finland; cQueen Mary Univeristy of London, London, UK; dUniversity of Eastern Finland, Kuopio, Finland
hrp0084fc4.5
Positive Association between Height and Cancer in the Swedish Population
aKarolinska Institutet, Stockholm, Sweden; bStockholm University, Stockholm, Sweden
hrp0084fc4.6